Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,523 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of microRNAs in ovarian cancer.
Kinose Y, Sawada K, Nakamura K, Kimura T. Kinose Y, et al. Among authors: nakamura k. Biomed Res Int. 2014;2014:249393. doi: 10.1155/2014/249393. Epub 2014 Sep 10. Biomed Res Int. 2014. PMID: 25295252 Free PMC article. Review.
IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment.
Kinose Y, Sawada K, Makino H, Ogura T, Mizuno T, Suzuki N, Fujikawa T, Morii E, Nakamura K, Sawada I, Toda A, Hashimoto K, Isobe A, Mabuchi S, Ohta T, Itai A, Morishige K, Kurachi H, Kimura T. Kinose Y, et al. Among authors: nakamura k. Mol Cancer Ther. 2015 Apr;14(4):909-19. doi: 10.1158/1535-7163.MCT-14-0696. Epub 2015 Jan 30. Mol Cancer Ther. 2015. PMID: 25637316
Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer.
Isobe A, Sawada K, Kinose Y, Ohyagi-Hara C, Nakatsuka E, Makino H, Ogura T, Mizuno T, Suzuki N, Morii E, Nakamura K, Sawada I, Toda A, Hashimoto K, Mabuchi S, Ohta T, Morishige K, Kurachi H, Kimura T. Isobe A, et al. Among authors: nakamura k. PLoS One. 2015 Feb 6;10(2):e0118080. doi: 10.1371/journal.pone.0118080. eCollection 2015. PLoS One. 2015. PMID: 25658637 Free PMC article.
Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination.
Nakatsuka E, Sawada K, Nakamura K, Yoshimura A, Kinose Y, Kodama M, Hashimoto K, Mabuchi S, Makino H, Morii E, Yamaguchi Y, Yanase T, Itai A, Morishige KI, Kimura T. Nakatsuka E, et al. Among authors: nakamura k. Oncotarget. 2017 Sep 12;8(52):89887-89902. doi: 10.18632/oncotarget.20834. eCollection 2017 Oct 27. Oncotarget. 2017. PMID: 29163796 Free PMC article.
14,523 results
You have reached the last available page of results. Please see the User Guide for more information.